The Total Return for Sinocare (SZSE:300298) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
The Total Return for Sinocare (SZSE:300298) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is really flourishing, you can make more than 100%. Long term Sinocare Inc. (SZSE:300298) shareholders would be well aware of this, since the stock is up 144% in five years. It's also good to see the share price up 18% over the last quarter. This could be related to the recent financial results, released recently - you can catch up on the most recent data by reading our company report.
在买入公司股票(假设没有杠杆作用)之后,最糟糕的结果是你损失了所有投入的钱。但是,当你选择一家真正蓬勃发展的公司时,你可以 使 超过 100%。长期 Sinocare Inc. (SZSE: 300298) 的股东们会很清楚这一点,因为该股在五年内上涨了144%。很高兴看到股价在上个季度上涨了18%。这可能与最近发布的最新财务业绩有关——您可以通过阅读我们的公司报告来了解最新数据。
Although Sinocare has shed CN¥879m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.
尽管Sinocare本周市值已下跌8.79亿元人民币,但让我们来看看其长期基本面趋势,看看它们是否推动了回报。
See our latest analysis for Sinocare
查看我们对Sinocare的最新分析
To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
引用巴菲特的话说:“船只将在世界各地航行,但Flat Earth Society将蓬勃发展。市场上的价格和价值之间将继续存在巨大差异...”研究市场情绪如何随着时间的推移而变化的一种方法是研究公司股价与其每股收益(EPS)之间的相互作用。
During five years of share price growth, Sinocare achieved compound earnings per share (EPS) growth of 3.4% per year. This EPS growth is slower than the share price growth of 20% per year, over the same period. So it's fair to assume the market has a higher opinion of the business than it did five years ago. That's not necessarily surprising considering the five-year track record of earnings growth.
在五年的股价增长中,Sinocare实现了每年3.4%的每股复合收益(EPS)增长。每股收益的增长低于同期股价每年20%的增长。因此,可以公平地假设市场对该业务的看法比五年前更高。考虑到五年的收益增长记录,这并不一定令人惊讶。
You can see below how EPS has changed over time (discover the exact values by clicking on the image).
你可以在下面看到 EPS 是如何随着时间的推移而变化的(点击图片发现确切的值)。
![earnings-per-share-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231107/0-1c111579cb9f34782bda8c25dcf3b4f7-0-e2d3ff3de2b5dff62f95e02563f19498.png/big)
It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Dive deeper into the earnings by checking this interactive graph of Sinocare's earnings, revenue and cash flow.
可能值得注意的是,首席执行官的薪水低于类似规模公司的中位数。但是,尽管首席执行官的薪酬总是值得检查的,但真正重要的问题是公司未来能否增加收益。查看这张Sinocare收益、收入和现金流的交互式图表,深入了解收益。
What About Dividends?
分红呢?
When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Sinocare, it has a TSR of 160% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.
在考虑投资回报时,重要的是要考虑两者之间的区别 股东总回报 (TSR) 和 股价回报。股价回报仅反映股价的变化,而股东总回报率包括股息的价值(假设股息已被再投资)以及任何折扣融资或分拆的收益。可以说,股东总回报率可以更全面地描述股票产生的回报。就Sinocare而言,其过去5年的股东总回报率为160%。这超过了我们之前提到的股价回报率。因此,该公司支付的股息促进了 总 股东回报。
A Different Perspective
不同的视角
While the broader market lost about 4.4% in the twelve months, Sinocare shareholders did even worse, losing 23% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 21% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Sinocare better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Sinocare , and understanding them should be part of your investment process.
尽管大盘在过去十二个月中下跌了约4.4%,但Sinocare股东的表现更糟,损失了23%(甚至包括股息)。话虽如此,在下跌的市场中,一些股票不可避免地会被超卖。关键是要密切关注基本发展。好的一面是,长期股东已经赚了钱,在过去的五年中,每年收益为21%。最近的抛售可能是一个机会,因此可能值得查看基本面数据以寻找长期增长趋势的迹象。长期跟踪股价表现总是很有意思的。但是,为了更好地了解Sinocare,我们需要考虑许多其他因素。例如,以永远存在的投资风险幽灵为例。 我们已经发现了 1 个警告标志 有了Sinocare,了解他们应该成为你投资过程的一部分。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
当然, 你可能会在其他地方找到一笔不错的投资。 所以来看看这个 免费的 我们预计的公司名单将增加收益。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们在一起。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。